Search by Drug Name or NDC
NDC 70121-1393-05 Doxercalciferol 2 ug/mL Details
Doxercalciferol 2 ug/mL
Doxercalciferol is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is DOXERCALCIFEROL.
MedlinePlus Drug Summary
Doxercalciferol injection is used to treat secondary hyperparathyroidism (a condition in which the body produces too much parathyroid hormone [PTH; a natural substance needed to control the amount of calcium in the blood] in people receiving dialysis (medical treatment to clean the blood when the kidneys are not working properly). Doxercalciferol injection is in a class of medications called vitamin D analogs. It works by helping the body to use more of the calcium found in foods or supplements and regulating the body's production of parathyroid hormone.
Related Packages: 70121-1393-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Doxercalciferol Injection
Product Information
NDC | 70121-1393 |
---|---|
Product ID | 70121-1393_0371cb71-1535-42f5-8aec-46c9bd3faa2c |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Doxercalciferol |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Doxercalciferol |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | ug/mL |
Substance Name | DOXERCALCIFEROL |
Labeler Name | Amneal Pharmaceuticals LLC |
Pharmaceutical Class | Ergocalciferols [CS], Vitamin D2 Analog [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA208974 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70121-1393-05 (70121139305)
NDC Package Code | 70121-1393-5 |
---|---|
Billing NDC | 70121139305 |
Package | 50 VIAL, SINGLE-DOSE in 1 CARTON (70121-1393-5) / 1 mL in 1 VIAL, SINGLE-DOSE (70121-1393-1) |
Marketing Start Date | 2017-05-24 |
NDC Exclude Flag | N |
Pricing Information | N/A |